Dietary Lipid Sequestration and Metabolic Rewiring in Colorectal Cancer: New Mechanistic Frontiers and Therapeutic Potential
Posted inClinical Updates Gastroenterology news Oncology

Dietary Lipid Sequestration and Metabolic Rewiring in Colorectal Cancer: New Mechanistic Frontiers and Therapeutic Potential

This review synthesizes recent evidence on how colorectal cancer tissues directly absorb extrinsic long-chain fatty acids from the intestinal lumen, particularly in right-sided tumors, and explores the critical interplay between lipid metabolism, the gut microbiome, and cancer cell proliferation.
Levothyroxine in the Ageing Patient: Re-evaluating Cardiovascular Outcomes in Subclinical Hypothyroidism through the ACEL-UK-ETT Trial
Posted inCardiology Clinical Updates Diabetes & Endocrinology news

Levothyroxine in the Ageing Patient: Re-evaluating Cardiovascular Outcomes in Subclinical Hypothyroidism through the ACEL-UK-ETT Trial

This review analyzes the ACEL-UK-ETT emulated target trial, demonstrating that long-term levothyroxine therapy in older adults with subclinical hypothyroidism significantly reduces cardiovascular events and all-cause mortality without compromising bone health, provided age-specific TSH thresholds are utilized.
Refining Surveillance for Unilateral Retinoblastoma: Integrating RB1 Genetic Status and Age at Diagnosis to Predict Bilateral Conversion
Posted inClinical Updates news Ophthalmology

Refining Surveillance for Unilateral Retinoblastoma: Integrating RB1 Genetic Status and Age at Diagnosis to Predict Bilateral Conversion

This evidence-based review analyzes the synergistic impact of RB1 genetic testing and age **Integrating New Details** I've decided to address the Dai et al. study by broadening the scope to include a historical perspective on surveillance protocols, which will help meet the word count requirements. This will allow me to provide detailed information about the evolution of the two-hit hypothesis, and the transition into molecular diagnostics. I'm also planning to discuss the impact of NGS/MLPA in depth. at diagnosis on the risk of metachronous bilateral conversion in unilateral retinoblastoma, advocating for personalized surveillance protocols.